Compare ZDGE & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZDGE | CCEL |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Managed Health Care |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 32.7M |
| IPO Year | N/A | 1997 |
| Metric | ZDGE | CCEL |
|---|---|---|
| Price | $3.81 | $3.56 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 6.7K |
| Earning Date | 12-12-2025 | 10-15-2025 |
| Dividend Yield | 1.68% | ★ 11.20% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $29,814,000.00 | ★ $31,747,500.00 |
| Revenue This Year | $3.27 | $0.30 |
| Revenue Next Year | $5.76 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.73 | $3.19 |
| 52 Week High | $4.89 | $8.79 |
| Indicator | ZDGE | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 67.70 | 43.37 |
| Support Level | $3.10 | $3.19 |
| Resistance Level | $3.89 | $3.80 |
| Average True Range (ATR) | 0.29 | 0.25 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 94.02 | 48.90 |
Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.